Apropos of diagnosis, prognosis and hormonal treatment of cancer of the prostate
Viollet, G.; Robin, M.; Colombeau, P.; Ciblac, G.
Journal d'Urologie et de Nephrologie 83(10-11): 896-900
1977
ISSN/ISBN: 0021-8200 PMID: 74419 Document Number: 122047
Document emailed within 1 workday
Related Documents
Lopez, J.G.; Perrin, P. 1999: Cancer of the prostate. Diagnosis, prognosis, principles of treatment La Revue du Praticien 49(3): 297-301Cubertafond, P.; Gainant, A.; Raymond, J. 1984: Gallbladder cancer in its early stages: current aspects of diagnosis, prognosis and treatment. Apropos of 30 cases Chirurgie; Memoires de l'Academie de Chirurgie 110(8-9): 729-733
Boccon-Gibod, L. 1987: Hormonal treatment in cancer of the prostate La Revue du Praticien 37(7): 386-390
De Voogt, H.J. 1986: Prostate cancer; hormonal treatment in a new stage? Nederlands Tijdschrift Voor Geneeskunde 130(17): 766-768
Faris, G.; Stein, A.; Lurie, A. 1993: Hormonal treatment of advanced prostate cancer Harefuah 124(1): 35-40
Autorino, R.; Di Lorenzo, G.; D'Armiento, F.P.; Mignogna, C.; Cindolo, L.; De Sio, M.; Perdona, S.; De Fortuna, E.; Salzano, L.; De Placido, S.; D'Armiento, M. 2005: Neuroendocrine differentiation after neoadjuvant hormonal treatment in prostate cancer Minerva Urologica e Nefrologica 57(4): 319-324
Jager, P.L.; Mensink, H.J.; van den Bergh, A.C.; Piers, D.A. 1999: A strontium-89 injection: a simple treatment of painful bone metastases in patients with prostate cancer unresponsive to hormonal treatment Nederlands Tijdschrift Voor Geneeskunde 143(19): 969-973
Hakariya, T.; Sakai, H. 2016: Efficacy and problems of new hormonal agents for the treatment of castration resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 137-142
Leewansangtong, S.; Soontrapa, S. 2003: The pattern of prostate-specific antigen responses following hormonal therapy in Thai men with bone metastatic prostate cancer Journal of the Medical Association of Thailand 86(9): 809-815
Utomo, N.B.; Mochtar, C.A.; Umbas, R. 2012: Primary hormonal treatment in localized and locally advanced prostate cancer: effectiveness and survival predictive factors Acta Medica Indonesiana 44(1): 10-15
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Strief, D.M. 2007: An overview of prostate cancer: diagnosis and treatment Urologic Nursing 27(6): 475-479; Quiz 480
Fuchsjäger, M.; Akin, O.; Shukla-Dave, A.; Pucar, D.; Hricak, H. 2009: The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer Clinical Advances in Hematology and Oncology: H&o 7(3): 193-202
Schlichting, E.; Buanes, T.; Stadaas, J.O. 1988: Gallbladder cancer. Occurrence, diagnosis, treatment and prognosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(10): 733-735
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Cao, X.-f.; Li, S.-q. 2011: Role of miRNA in the diagnosis, prognosis and treatment of esophageal cancer Zhonghua Zhong Liu Za Zhi 33(3): 161-164
Descamps, P.; Galais, G.; Body, G.; Lansac, J. 1992: Cancer of the endometrium. Epidemiology, diagnosis, development, prognosis, treatment La Revue du Praticien 42(18): 2365-2371
Miki, T.; Kamoi, K. 2001: Neoadjuvant hormonal therapy for prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(7): 927-933
Trachtenberg, J. 1994: State-of-the-art hormonal management of prostate cancer Canadian Journal of Urology 1(3): 49-52
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910